Does ‘Strong Analgesic’ Equal ‘Strong Opioid’? Tapentadol and the Concept of ‘µ-Load’ Robert B. RaffaChristian EllingThomas M. Tzschentke Commentary Open access 11 September 2018 Pages: 1471 - 1484
A Charter to Improve Patient Care in Severe Asthma Andrew Menzies-GowG-Walter CanonicaAntje-Henriette Fink-Wagner Commentary Open access 04 September 2018 Pages: 1485 - 1496
An Update of Efficacy and Safety of Cetuximab in Metastatic Colorectal Cancer: A Narrative Review Giulia FornasierSara FrancesconPaolo Baldo Review 14 September 2018 Pages: 1497 - 1509
Current and Emerging Treatment Modalities for Leber’s Hereditary Optic Neuropathy: A Review of the Literature Anna Theodorou-KanakariSpyridon KarampitianisIrini Chatziralli Review Open access 01 September 2018 Pages: 1510 - 1518
Diagnosis and Management of Hypothyroidism: Addressing the Knowledge–Action Gaps Sanjay KalraA. K. DasNitin Mulgaonkar Review 31 August 2018 Pages: 1519 - 1534
Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review Paul EmeryJanet E. PopeBlerina Kola Review Open access 20 August 2018 Pages: 1535 - 1563
Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States Sunnie KimJames E. SignorovitchJohn L. Marshall Original Research Open access 12 September 2018 Pages: 1564 - 1577
Diagnostic Accuracy of Bronchodilator Response for Asthma in a Population of South China Shichuan ZhangChengping HuJuntao Feng Original Research 12 September 2018 Pages: 1578 - 1584
Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment Roger A. EdwardsGianluca BonfantiJoe Alexander Original Research Open access 11 September 2018 Pages: 1585 - 1597
72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension Hirofumi OchiMasaaki NiinoShinichi Torii Original Research Open access 11 September 2018 Pages: 1598 - 1611
Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data Tingjian YanMallik GreeneMichael S. Broder Original Research Open access 11 September 2018 Pages: 1612 - 1625
Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β2-Agonist Therapy: An Integrated Post Hoc Analysis Ian P. NayaLee TombsChris Compton Original Research Open access 06 September 2018 Pages: 1626 - 1638
Treatment Duration, Healthcare Resource Utilization, and Costs Among Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis Neil M. SchultzScott C. FlandersVahan Kassabian Original Research Open access 06 September 2018 Pages: 1639 - 1655
Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample Marco CalabròLaura MandelliAlessandro Serretti Original Research Open access 03 September 2018 Pages: 1656 - 1670
Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States Karen SeiterDominick Latremouille-ViauGeorge J. Joseph Original Research 28 August 2018 Pages: 1671 - 1685
Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy Molly F. PurserDeirdre M. MladsiJohn Forsey Original Research Open access 24 August 2018 Pages: 1686 - 1696
Correction to: Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy Molly F. PurserDeirdre M. MladsiJohn Forsey Correction Open access 12 September 2018 Pages: 1697 - 1697
Combination Antihypertensive Therapy with Perindopril and Indapamide in Patients with Essential Hypertension: Effect on Endothelial and Cognitive Markers of Vascular Improvement Elena A. ZheleznykhYulia A. DanilogorskayaMikhail I. Tishman Original Research 20 August 2018 Pages: 1698 - 1712
Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia Olga RůžičkováZdenko KillingerLama Kalouche-Khalil Brief Report Open access 06 September 2018 Pages: 1713 - 1728